Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01499680 · ClinicalTrials.gov registry record
Multimodality Neuromonitoring in XLIF
A clinical trial of Degeneration of Lumbar Intervertebral Disc, sponsored by NuVasive.
- Completed
- Registry status
- 323
- Enrollment target
- 20
- Study locations
NCT01499680 is a study of Degeneration of Lumbar Intervertebral Disc that has completed, run by NuVasive. The registered enrollment target is 323 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT01499680, a study of Degeneration of Lumbar Intervertebral Disc, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 323 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, non-randomized multi-center study to evaluate intraoperative neuromonitoring results in subjects who undergo eXtreme Lateral Interbody Fusion (XLIF) surgery at any number of levels inclusive of L4-5.
Conditions Studied
Study Locations (20)
Georgia
- West Augusta Spine Specialists - Augusta
- Georgia Spine and Neurosurgery Center - Decatur
- Pinnacle Orthopaedics and Sports Medicine - Marietta
California
- Shiley Center for Orthopaedic Research - La Jolla
- UC Irvine Medical Center - Orange
Illinois
- McLean Country Orthopedics - Bloomington
- Illinois Neurological Institute - Peoria
Missouri
- Columbia Orthopaedic Group - Columbia
- Spine Midwest, Inc. - Jefferson City
Pennsylvania
- Univerisity of Pittsburgh Medical Center - Pittsburgh
- University of Pittsburgh Medical Center - Pittsburgh
Colorado
- Durango Orthopaedics - Durango
Florida
- USF Neurology and Neurosurgery - Tampa
Nevada
- Western Regional Center for Brain and Spine Surgery - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01499680
The ClinicalTrials.gov registry entry for NCT01499680 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degeneration of Lumbar Intervertebral Disc appearing as the primary indexed condition, and to 0 interventions.
NCT01499680 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Georgia, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT01499680 about?
NCT01499680 is a clinical study titled "Multimodality Neuromonitoring in XLIF". This is a prospective, non-randomized multi-center study to evaluate intraoperative neuromonitoring results in subjects who undergo eXtreme Lateral Interbody Fusion (XLIF) surgery at any number of levels inclusive of L4-5.
What is the current status of trial NCT01499680?
This trial is currently completed. The enrollment target is 323 participants. The study started on 2011-10. Estimated completion is 2014-06.
What conditions does trial NCT01499680 study?
This clinical trial studies the following conditions: Degeneration of Lumbar Intervertebral Disc.
Who is sponsoring clinical trial NCT01499680?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01499680 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degeneration of Lumbar Intervertebral Disc
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.